146 related articles for article (PubMed ID: 27530243)
1. Drug-drug interactions of cytostatics with regular medicines in lung cancer patients.
Rompelman FM; Smit AA; Franssen EJ; Crul M
J Oncol Pharm Pract; 2017 Oct; 23(7):483-490. PubMed ID: 27530243
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and patient awareness of selected potential drug interactions with self-medication.
Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers.
Schindler F; Schinkoethe T; Mahner S; Kolben T; Wuerstlein R; Culmsee C; Harbeck N; Eggersmann TK
Ther Adv Drug Saf; 2023; 14():20420986231188845. PubMed ID: 37636837
[TBL] [Abstract][Full Text] [Related]
4. Medication surveillance on intravenous cytotoxic agents: a retrospective study.
van Oijen B; Janknegt R; de Wit H; Peters F; Schouten H; van der Kuy H
Int J Clin Pharm; 2013 Aug; 35(4):554-9. PubMed ID: 23585184
[TBL] [Abstract][Full Text] [Related]
5. Drug interactions with oral antineoplastic drugs: The role of the pharmacist.
Riu-Viladoms G; Carcelero San Martín E; Martín-Conde MT; Creus N
Eur J Cancer Care (Engl); 2019 Jan; 28(1):e12944. PubMed ID: 30324634
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical counseling: Between evidence-based medicine and profits.
Egorova SN; Akhmetova T
Int J Risk Saf Med; 2015; 27 Suppl 1():S87-8. PubMed ID: 26639727
[TBL] [Abstract][Full Text] [Related]
8. Drug-drug interactions in pediatric oncology patients.
Balk TE; van der Sijs IH; van Gelder T; Janssen JJB; van der Sluis IM; van Leeuwen RWF; Engels FK
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28205376
[TBL] [Abstract][Full Text] [Related]
9. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
Desmaele S; De Wulf I; Dupont AG; Steurbaut S
Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
[TBL] [Abstract][Full Text] [Related]
10. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.
Bellesoeur A; Gataa I; Jouinot A; Mershati SE; Piketty AC; Tlemsani C; Balakirouchenane D; Monribot A; Vidal M; Batista R; de Percin S; Villeminey C; Alexandre J; Goldwasser F; Blanchet B; Boudou-Rouquette P; Thomas-Schoemann A
Cancer Chemother Pharmacol; 2021 Oct; 88(4):741-751. PubMed ID: 34304283
[TBL] [Abstract][Full Text] [Related]
12. Falls prevention focused medication review by a pharmacist in an acute hospital: implications for future practice.
Browne C; Kingston C; Keane C
Int J Clin Pharm; 2014 Oct; 36(5):969-75. PubMed ID: 25108410
[TBL] [Abstract][Full Text] [Related]
13. Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs.
Voll ML; Yap KD; Terpstra WE; Crul M
Pharm World Sci; 2010 Oct; 32(5):575-80. PubMed ID: 20645002
[TBL] [Abstract][Full Text] [Related]
14. The 'third class' of medications: Sales and purchasing behavior are associated with pharmacist only and pharmacy medicine classifications in Australia.
Emmerton L
J Am Pharm Assoc (2003); 2009; 49(1):31-7. PubMed ID: 19196594
[TBL] [Abstract][Full Text] [Related]
15. Impact of a specialist clinical cancer pharmacist at a multidisciplinary lung cancer clinic.
Walter C; Mellor JD; Rice C; Kirsa S; Ball D; Duffy M; Herschtal A; Mileshkin L
Asia Pac J Clin Oncol; 2016 Sep; 12(3):e367-74. PubMed ID: 25227909
[TBL] [Abstract][Full Text] [Related]
16. Performance of community pharmacists in providing clinical medication reviews.
Laaksonen R; Duggan C; Bates I
Ann Pharmacother; 2010; 44(7-8):1181-90. PubMed ID: 20571102
[TBL] [Abstract][Full Text] [Related]
17. Impact of pharmacist-led medication management in care transitions.
Yang S
BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
[TBL] [Abstract][Full Text] [Related]
18. Role of clinical pharmacists to prevent drug interactions in cancer outpatients: a single-centre experience.
Lopez-Martin C; Garrido Siles M; Alcaide-Garcia J; Faus Felipe V
Int J Clin Pharm; 2014 Dec; 36(6):1251-9. PubMed ID: 25326824
[TBL] [Abstract][Full Text] [Related]
19. Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases.
Prely H; Herledan C; Caffin AG; Baudouin A; Larbre V; Maire M; Schwiertz V; Vantard N; Ranchon F; Rioufol C
J Cancer Res Clin Oncol; 2022 Mar; 148(3):707-718. PubMed ID: 33914124
[TBL] [Abstract][Full Text] [Related]
20. Patients' knowledge of new medicines after discharge from hospital: What are the effects of hospital-based discharge counseling and community-based medicines use reviews (MURs)?
Elson R; Cook H; Blenkinsopp A
Res Social Adm Pharm; 2017; 13(3):628-633. PubMed ID: 27283244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
